Get started
Author

Stefanie Reif

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
2016 · A. Patnaik, L.J. Appleman, et al. · Annals of Oncology · 239
PDF
Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath ® ) in patients with chronic lymphocytic leukaemia and its link to treatment response
2007 · D. R. Mould, A. Baumann, et al. · British Journal of Clinical Pharmacology · 117
Effect of grapefruit juice intake on etoposide bioavailability
2002 · Stefanie Reif, Marianne Nicolson, et al. · European Journal of Clinical Pharmacology · 79
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours
2001 · G Fleischhack, S Reif, et al. · British Journal of Cancer · 59
PDF
Pharmacokinetics and Safety of Gadobutrol-Enhanced Magnetic Resonance Imaging in Pediatric Patients
2009 · Gabriele Hahn, Ina Sorge, et al. · Investigative Radiology · 50
High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis
2006 · K Steiner, M Graf, et al. · Leukemia · 47
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
2009 · P. Schmid, P. Kiewe, et al. · Annals of Oncology · 41
PDF
A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors
2005 · P. Schmid, P. Kiewe, et al. · Journal of Clinical Oncology · 38
High-performance liquid chromatographic determination of ropivacaine, 3-hydroxy-ropivacaine, 4-hydroxy-ropivacaine and 2′,6′-pipecoloxylidide in plasma
1998 · Stefanie Reif, Pascal Le Corre, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 33
Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
2012 · Hartmut Blode, Kristin Kowal, et al. · The European Journal of Contraception & Reproductive Health Care · 31
PDF
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial
2009 · D Arnold, W Voigt, et al. · British Journal of Cancer · 31
PDF
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients
2001 · Stefanie Reif, Dorothea Kingreen, et al. · Cancer Chemotherapy and Pharmacology · 21
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis
2023 · Jan Hilpert, Esther Groettrup-Wolfers, et al. · Drugs in R&D · 19
PDF
Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity
2007 · Stefan Wilde, Alexander Jetter, et al. · Clinical Pharmacokinetics · 19
Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study
2013 · Stefanie Reif, Nelleke Snelder, et al. · Journal of Family Planning and Reproductive Health Care · 16
PDF
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers
2017 · Michael Gerisch, Thomas Schwarz, et al. · Cancer Chemotherapy and Pharmacology · 15
PDF
Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
2023 · Isabella Gashaw, Stefanie Reif, et al. · European Journal of Endocrinology · 9
Population pharmacokinetics of cyclo- phosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy
2002 · S. Wilde, A. Jetter, et al. · International Journal of Clinical Pharmacology and Therapeutics · 9
From Adults to Children
2012 · Stefanie Reif, Marcus Schultze-Mosgau, et al. · Pediatric Drugs · 8
Population Pharmacokinetics Analysis of Regorafenib and Its Active Metabolites From the Phase III Correct Study of Metastatic Colorectal Cancer
2013 · Zuzana Jirakova Trnkova, Axel Grothey, et al. · Annals of Oncology · 7
Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.
2014 · Richard D. Kim, Steven R. Alberts, et al. · Journal of Clinical Oncology · 6
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
2001 · D Kingreen, J Beyer, et al. · PubMed · 5
Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide
2003 · C. Sirisangtragul, G. Henke, et al. · International Journal of Clinical Pharmacology and Therapeutics · 4
Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers
2023 · Stefanie Reif, Marcus-Hillert Schultze-Mosgau, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 1
Effects of rifampin on the pharmacokinetics of copanlisib, a novel pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor in cancer patients.
2018 · Anna Spreafico, Michael B. Sawyer, et al. · Journal of Clinical Oncology · 1
Works count: 35
Citation count: 904
H-index: 15
I10-index: 16
Year
Topic
Type